CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-03 | Hindson Benjamin J. Director | Sale | −7,353 | $137.57 | $1.0M | 67,795 |
| 2020-11-03 | Hindson Benjamin J. Director | Sale | −295 | $138.49 | $41K | 67,500 |
| 2020-11-03 | Hindson Benjamin J. Director | Exercise or conversion · Stock Option (right to buy) | −12,688 | 78,750 | ||
| 2020-11-03 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Exercise or conversion | +6,496 | $1.16 | $8K | 7,459 |
| 2020-11-03 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Sale | −200 | $135.42 | $27K | 7,259 |
| 2020-11-03 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Sale | −2,198 | $136.60 | $300K | 5,061 |
| 2020-11-03 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Sale | −3,898 | $137.56 | $536K | 1,163 |
| 2020-11-03 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Sale | −200 | $138.43 | $28K | 963 |
| 2020-11-03 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) | −6,496 | 647,000 | ||
| 2020-11-02 | STUELPNAGEL JOHN R Director | Sale | −2,328 | $135.62 | $316K | 516,163 |
| 2020-11-02 | STUELPNAGEL JOHN R Director | Sale | −3,900 | $136.23 | $531K | 512,263 |
| 2020-11-02 | STUELPNAGEL JOHN R Director | Sale | −772 | $137.47 | $106K | 511,491 |
| 2020-11-02 | STUELPNAGEL JOHN R Director | Sale | −500 | $139.03 | $70K | 510,991 |
| 2020-11-02 | Saxonov Serge Chief Executive Officer | Exercise or conversion | +6,250 | $1.20 | $8K | 973,431 |
| 2020-11-02 | Saxonov Serge Chief Executive Officer | Exercise or conversion | +826 | $5.04 | $4K | 974,257 |
| 2020-11-02 | Saxonov Serge Chief Executive Officer | Sale | −1,624 | $135.45 | $220K | 972,633 |
| 2020-11-02 | Saxonov Serge Chief Executive Officer | Sale | −4,052 | $136.13 | $552K | 968,581 |
| 2020-11-02 | Saxonov Serge Chief Executive Officer | Sale | −500 | $137.10 | $69K | 968,081 |
| 2020-11-02 | Saxonov Serge Chief Executive Officer | Sale | −900 | $138.54 | $125K | 967,181 |
| 2020-11-02 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −6,250 | 116,110 |
Page 55 of 57 · 1,128 trades